First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics…
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company…
The Cell and Gene Therapy Catapult (CGT Catapult) and the UK Dementia Research Institute (UK…
TILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…
U.S. biotech company Athersys, Inc. has announced a corporate restructuring plan to reduce costs and…
German headquartered life science company Evotec SE has acquired 100% of the capital of Rigenerand…
Cell cultures are extensively used in basic and translational life science research. Common methods for…
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
Despite several high-profile trial failures in the field, multiple players are getting close to the…
The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease…